Wegovy has gained attention as a powerful weight loss medication, especially for those struggling with obesity. However, if you're on Medicare or soon will be, you may be wonderi

Medicare covers certain obesity-related treatments like counseling and surgeries but typically not weight loss programs for general health. It also currently doesn’t cover obesity medications ...

Minnesota lawmakers are once again calling on insurance companies to cover anti-obesity medications like Ozempic and Wegovy as more Americans flock to the drugs to help lose weight.

Wave goodbye to the Part D "donut hole" and hello to a $2,000 cap on the amount you'll pay for medications. But other changes may be less welcome. Here's what to expect.

Obesity Care Week (OCW) returns for its annual global campaign aimed at raising awareness, educating and advocating for individuals affected by obesity. This year's theme, "Commit to Care," emphasizes the urgent need for accessible,

New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising rates of type 2 diabetes and obesity.

Medicare, the government-backed program for ... Ozempic, which has also been used off-label for obesity, saw a more than 16-fold rise in spending to $9.2 billion in 2023 from 2019 - roughly ...

Many employers and insurers are scaling back coverage of Wegovy and Zepbound and a key government program, Medicare, doesn’t cover the drugs for obesity. Meanwhile, some big employers are adding ...